| GCA | Gastric-type cervical adenocarcinoma |
| UCA | Usual-type cervical adenocarcinoma |
| PFS | Progression-free survival |
| OS | Overall survival |
| FIGO | International Federation of Gynecology and Obstetrics |
| ICI | Immune checkpoint inhibitor |
| GCA | Gastric-type cervical adenocarcinoma |
| UCA | Usual-type cervical adenocarcinoma |
| PFS | Progression-free survival |
| OS | Overall survival |
| FIGO | International Federation of Gynecology and Obstetrics |
| ICI | Immune checkpoint inhibitor |